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Ahead of the Curve
 The United States Critical Illness and Injury Trials 
(USCIIT) Group created clinical research infrastructure 
to reduce the barriers to investigation for the critical 
illness and injury communities in the United States. 1 
As an inclusive, grassroots “network of networks,” the 
USCIIT Group’s dual missions are to foster investigator-
initiated hypothesis testing and to develop recommen-
dations for strategic plans at a national level. 2 The 
USCIIT Group was funded in 2008 by a National Insti-
tutes of Health (NIH) (National Institute of General 
Medical Science) meeting grant (U13) with four aims 3 : 
  1.  Establish an inclusive, nationwide network of 
experts to review published data, vet hypotheses, 
write clinical protocols, and generate pilot data 
that facilitate implementation of large clinical 
trials. 
 The United States Critical Illness and Injury Trials (USCIIT) Group is an inclusive, grassroots 
“network of networks” with the dual missions of fostering investigator-initiated hypothesis testing 
and developing recommendations for strategic plans at a national level. The USCIIT Group’s 
transformational approach enlists multidisciplinary investigative teams across institutions, crit-
ical illness and injury professional organizations, federal agencies that fund clinical and transla-
tional research, and industry partners. The USCIIT Group is endorsed by all major critical illness 
and injury professional organizations spanning the specialties of anesthesiology, emergency 
medicine, internal medicine, neurology, nursing, pediatrics, pharmacy and nutrition, surgery and 
trauma, and respiratory and physical therapy. Recent successes provide the opportunity to signif-
icantly increase the dialogue necessary to advance clinical and translational research on behalf of 
our community. More than 200 investigators are now involved across  . 30 academic and commu-
nity hospitals. Collectively, USCIIT Group investigators have enrolled  . 10,000 patients from 
academic and community hospitals in studies during the last 3 years. To keep our readership 
“ahead of the curve,” this article provides a vision for critical illness and injury research based on 
(1) programmatic organization of large-scale, multicentered collaborative studies and (2) annual 
strategic planning at a national scale across disciplines and stakeholders. 
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era of health services and comparative effectiveness 
research, as described recently by the leadership 
of the NIH, the Agency for Healthcare Research 
and Quality, and the new Patient-Centered Outcomes 
Research Institute. 7,8 A spectrum of important deliv-
erables is expected, including, but not limited to, the 
following: 
  •  Create of a “network of networks” for critical ill-
ness and injury research for rapid data sharing, 
analysis, and reporting, leveraging the existing 
research infrastructure across 60 sites in the CTSA 
network. 
  •  Effi ciently conduct (in terms of recruitment and 
funding spent) multicentered studies, the results 
of which lead to optimized outcomes and reduce 
unwanted practice variance. 
  •  Coordinate peer review for research protocol gen-
eration and presentation of consensus policies, 
procedures, results, and recommendations. 
  •  Harmonize institutional review board submis-
sions, working with national organizations such 
as the Public Health Ethical Research Review 
Board. 
  •  Organize research education and training across 
the 60 sites supported by the NIH CTSAs. 
  •  Facilitate communication and create infrastructure 
to promote national emergency preparedness. 
  •  Establish biobanks linked to robust clinical data-
bases that can be used to identify biomarkers and 
genetic variation associated with outcome. 
 Finally, to address its missions globally, the USCIIT 
Group participates in the International Form of Acute 
Care Trialists (InFACT), a collaborative network of 
investigator-led research groups. 9 
 Vision 
 The USCIIT Group’s collaborative approach enlists 
multidisciplinary investigative teams across institutions, 
critical illness and injury professional organizations, 
federal agencies that fund clinical and translational 
research, and industry partners. Recent successes pro-
vide the opportunity to signifi cantly increase the dia-
logue necessary to advance clinical and translational 
research on behalf of our community. Operationally, 
this will depend upon leveraging resources available 
through the new CTSA Thematic Special Interest 
Group (NIH National Center for Advancing Trans-
lational Science; NCATS) and improved coordination 
of strategic planning with the Critical Care Societies 
Collaborative (American Association of Critical Care 
Nurses, American College of Chest Physicians, Ameri-
can Thoracic Society, and Society of Critical Care 
Medicine). 
  2.  Promote interactions and synergy across estab-
lished research programs, both academic and 
nonacademic, to improve the robustness of clin-
ical trials and test hypotheses in a US population. 
  3.  Provide a venue to discuss education and train-
ing in the science of clinical trial design, con-
duct, analysis, and reporting for critically ill or 
injured patients. 
  4.  Ensure patient protection and privacy by address-
ing the ethical, legal, and social implications of 
research in the specialized circumstance of crit-
ical illness or injury. 
 To these ends, the USCIIT Group provides a 
biweekly teleconference venue for investigator and 
NIH interinstitute communications; engages in a mul-
tisociety task force for annual research strategic plan-
ning; catalyzes Health and Human Services inter agency 
dialogue for endorsement of transforming initia-
tives; seeks to coordinate research training nation-
ally as a Clinical and Translational Science Award 
(CTSA) Thematic Special Interest Group; and fos-
ters innovative, multidisciplinary, multicenter studies 
that typically start as investigator-driven clinical pro-
posals. Typically, hypotheses are tested by multidisci-
plinary teams that openly solicit input and encourage 
collaboration among investigators with similar inter-
ests across institutions. The USCIIT Group is gov-
erned by a steering committee of investigators and 
by an organizing committee composed primarily of 
Health and Human Services staff. The USCIIT Group 
involves  . 200 investigators across  . 30 academic 
and community hospitals. Collectively, USCIIT Group 
investigators have enrolled  . 10,000 patients from 
academic and community hospitals in studies during 
the last 3 years. 4,5 
 Signifi cance 
 The USCIIT Group is endorsed by all major critical 
illness and injury professional organizations spanning 
the specialties of anesthesiology, emergency medi-
cine, internal medicine, neurology, nursing, pediatrics, 
pharmacy and nutrition, surgery and trauma, and respi-
ratory and physical therapy. The transformative nature 
of the USCIIT Group and its unique role in the United 
States have been recognized. 6 The group plays an 
important role, as there is no federal agency or national 
organization in the United States that facilitates crit-
ical illness and injury research or strategic planning 
across specialties and the human developmental 
continuum. The USCIIT Group Thematic Special 
Interest Group also provides a new opportunity to 
leverage the huge investment in infrastructure across 
60 academic sites (nodes) in the CTSA network. Finally, 
the USCIIT Group provides a network for the new 
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facilitate care in the ICU with built-in tools for best 
practice compliance, practice surveillance, decision 
support, and reporting. 
 Program for Critical Illness Outcomes:  Care deliv-
ered in ICUs is high intensity and high cost and has 
remarkable variation in use and outcomes. Variations 
have been described with individual features such as 
geographic locale, ICU and provider specialization, 
and patient acute disease and illness severity, among 
other factors. To date, little is known about which 
ICU organizational and structural factors are associated 
with high-quality care and optimal patient outcomes. 
To determine which of these factors are associated 
with high-quality critical care and relevant clinical out-
comes, USCIITG-Program for Critical Illness Outcomes 
(USCIITG-CIOS) has collected both ICU-specifi c 
and patient-specifi c data on  . 6,000 patients from  . 60 
US ICUs. 5 This fi rst-outcomes study found substan-
tial variation in protocol availability and use—with 
the majority of ICUs having   16 protocols in place—
and patient mortality was noted to vary according 
to ICU type (medical vs surgical vs mixed). In future 
outcomes studies, USCIITG-CIOS will increase our 
understanding of the relationship between multi-
professional ICU staffi ng, care pathway and proto-
col use, and patient-centered clinical outcomes. In so 
doing, it permits testing a number of new methods of 
optimizing ICU patient care, both at the patient level 
(which patients, when, and how best to deliver the 
care) and institutional level (staffi ng, protocols and 
pathways, and so forth). This will identify hypotheses 
to test in novel effectiveness trials at the regional, state, 
and national levels. 
 Program for Emergency Preparedness:  National 
emergencies over the past decade demonstrated that 
the US federal emergency response system had insuffi -
cient capabilities to rapidly collect clinical data to 
inform decision-makers and key end-users in public 
health emergencies. In particular, physiologic patient 
data are needed to provide immediate insight into the 
impact of the event on critical health-care resources 
and to identify groups with high risk for morbidity and 
mortality. The USCIIT Group Program for Emergency 
Preparedness (USCIITG-PREP) aims to signifi cantly 
enhance the national capability to rapidly glean cru-
cial information regarding the clinical course of acute 
illness and injury and guide clinical resource require-
ments during emergent events. Working with leading 
professional organizations and the Homeland Security 
Information Network, USCIITG-PREP will develop 
mechanisms for rapid data collection, analysis, and 
dissemination of fi ndings during public health emer-
gencies. Pre-event work on protocols, data collection 
processes, rapid analysis techniques, and means to 
quickly disseminate fi ndings to stakeholders are all 
 Investigator-Initiated Hypothesis Testing 
 The foundation of the USCIIT Group’s hypothesis-
testing enterprise is the interest of an individual 
investigator to present a clinical proposal that tests a 
hypothesis, working in collaboration with a multidis-
ciplinary, multi-institutional team. To date,  . 50 clin-
ical proposals have been presented at USCIIT Group 
meetings, with most still in the design phase. Several 
have started enrollment, and a few have completed 
analysis and published results. The most mature of 
these USCIIT Group multidisciplinary programs have 
used these results as preliminary data to support fed-
erally funded, large, multi-institutional studies. As the 
USCIIT Group evolves, we expect that this hypothesis-
testing pathway will increase in throughput. Several 
examples of programmatic development are provided 
here. 
 Program for Prevention of Organ Failures:  Efforts 
to prevent organ failure are hampered by three bar-
riers: (1) compartmentalization of care (ED, oper-
ating room, ICU, and so forth); (2) the diffi culty of 
identifying early those at risk; and (3) lack of proven, 
effective treatments. Building on the success of the 
Lung Injury Prevention Study (USCIITG-LIPS), 4,10 
the unique, multidisciplinary, USCIIT Group network, 
and CTSA-funded infrastructure, USCIITG-Program 
for Prevention of Organ Failures (USCIITG-PROOF) 
will address all three barriers simultaneously through 
rapid-cycle, multicenter clinical trials that span clinical 
domains to test a variety of interventions that prevent 
organ failure in those at risk. USCIITG-PROOF inves-
tigators currently are working on multiple projects 
aimed at the prevention of acute lung injury, including 
LIPS-Aspirin (LIPS-A) (a National Heart, Lung, and 
Blood Institute-funded multicenter trial to investi-
gate the usefulness of aspirin to prevent acute lung 
injury) and LIPS-B, an investigator-initiated study 
to examine whether budesonide and the  b -agonist 
formoterol can prevent acute lung injury in high-risk 
patients. Additionally, USCIITG-PROOF will advance 
the methodology used to conduct clinical trials, moving 
away from existing manual data collection techniques 
toward automated extraction of clinical data from 
electronic medical records. The fi rst test of this tech-
nology will come from a Centers for Medicare and 
Medicaid Services -sponsored, multicenter innovation 
award with USCIIT Group investigators and Philips 
Research North America. The goal of this project is 
to determine whether a novel acute care interface, 
Patient-Centered Cloud-Based Electronic System-
Ambient Warning and Response Evaluation (ProCCESs 
AWARE), can reduce preventable errors in the ICU, 
improve outcomes, and reduce costs and, in the pro-
cess, train  . 1,400 providers to use state-of-the-art 
acute care informatics. 11 ProCCESs AWARE aims to 
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Consistent with our recently published research agenda 
and the NCATS mission, we will create a consensus 
strategic plan for advanced informatics, education and 
training, and multicenter clinical trials that leverages 
regional and national CTSA infrastructure. 
 Other Programs:  In addition to these broader areas, 
there are a number of other programs for targeted 
disease states, such as burn injury and trauma, cur-
rently in development. In other words, we expect over 
time that the number of USCIIT Group programs 
will increase, consistent with the USCIIT Group’s dual 
missions and the strategic imperatives described in 
our recently published national research agenda (see 
the following ). For example, a new program to opti-
mize tracheostomy practice seeks to address variance 
in practice (including timing of procedure and tech-
nical approach), determine which patient populations 
(if any) benefi t from earlier tracheostomy, identify 
metrics for patient-centric outcomes, and optimize 
post-tracheostomy management. 16 
 Strategic Planning 
 The USCIIT Group has been at the forefront of 
recent efforts to identify and address key areas in 
critical illness and injury research, as articulated by 
investigators, professional organizations, funding agen-
cies, and regulators. For instance, the USCIIT Group 
annual meetings have served as an interdisciplinary 
forum for dialogues among key critical illness and 
injury research stakeholders, including federal fund-
ing agencies, professional organizations, and regula-
tory agencies. More information and the broad array 
of session topics and speakers from previous and 
future meetings can be found on the USCIIT Group 
website. 3 
 New Alliance for Critical Illness and Injury Research: 
 As part of this “new alliance,” 1,6 the USCIIT Group 
worked with the Critical Care Societies Collaborative 
(CCSC) to lead the development of a comprehen-
sive, strategic research agenda for critical illness and 
injury. Funded by the National Heart, Lung, and Blood 
Institute, a 2-day, multicare setting, multidisciplinary 
meeting was held, the conclusions of which were pub-
lished simultaneously by the offi cial organs of the 
CCSC organizations. 17-20 This CCSC-USCIIT Group 
report delineated challenges, specifi c priority areas, 
and recommendations for improvements in critical care 
research infrastructure and processes. For example, 
four overarching themes were identifi ed: modify the 
“silo-ed” approach to critical care research; embrace 
linkage of basic, clinical, and translational research; 
account for disease complexity and patient heteroge-
neity; and enhance critical care research infrastruc-
ture. 17-20 The report also emphasizes that continued, 
crucial to making clinical science networks effective 
at enhancing the response. The USCIIT Group will 
leverage existing infrastructure to both strengthen 
pre-event operational science capabilities and pro-
vide timely data and situational awareness across 
the emergency-care continuum during public health 
emergencies. 
 Program for Early ICU Rehabilitation:  Physiatrists, 
physical therapists, respiratory therapists, speech-
language pathologists, and occupational therapists 
are essential for coordinating rehabilitation of critically 
ill or injured patients. Early rehabilitation can help 
to ameliorate and even avoid severe deconditioning 
associated with post-ICU syndrome, which presents 
as long-term physical, cognitive, and mental health 
problems after severe critical illness or injury. 12-14 
USCIITG Program for Early ICU Rehabilitation 
(USCIITG-PEIR) seeks to identify areas of hetero-
geneity of care and to improve early rehabilitation for 
critically ill or injured patients. USCIITG-PEIR soon 
will launch a multicenter, randomized controlled clin-
ical trial to measure the effect of early rehabilitation 
on hospital stay, muscle loss, and functional outcomes 
in burn patients with acute respiratory failure. In 
addition, a “point in time” observation study will be 
conducted to sample current rehabilitation strategies 
among ICUs nationally. 
 CTSA Thematic Special Interest Group:  As an addi-
tional approach to accelerate progress in our fi eld, 
the USCIIT Group will leverage the resources of 
the NIH CTSAs, now funded by the NCATS. Since 
2006, CTSAs have supported leading US academic 
research centers to create infrastructure for transla-
tional research, to promote the training and career 
development of clinical and translational researchers, 
to develop innovative methods and technologies that 
strengthen translational research, and to create local 
core resources through a national dialogue of shared 
practice. 15 The recent creation of CTSA Thematic 
Special Interest Groups provides the opportunity for 
investigators to leverage the extraordinary resources the 
60 CTSA sites provide in aggregate, in effect creating 
a 60-node national research network for phenotypic-
specifi c (“thematic”) research. CTSA collaborative 
expertise is available for drug discovery; statistics; 
clinical epidemiology; trial design; prevention and 
personalized medicine; public-private partnerships; 
ethics and regulatory affairs; research education, train-
ing, and career development; comparative effectiveness 
research; and health services research. The USCIITG-
Thematic Special Interest Group (USCIITG-TSIG) 
will expand the scope and impact of USCIIT Group 
operations, working in partnership with investigators 
located at these 60 CTSA-funded research centers. 
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 Role of sponsors: The sponsors had no role in the design of the 
study, the collection and analysis of the data, or in the preparation 
of the manuscript. 
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broad-based, strategic planning will be necessary to 
maintain and adjust research priorities as knowl-
edge advances; the vision is to revise and refresh this 
national research agenda on a regular basis, perhaps 
biannually. 
 Offi ce of Emergency Care Research:  The need 
for a dedicated centralized offi ce at the NIH for 
emergency care research was recognized in the 2007 
Institute of Medicine Report on Emergency Care. 21 
Emergency care research frequently studies highly 
dynamic, multiorgan pathophysiology in patients with 
undifferentiated signs and symptoms. This type of 
research inherently intersects multiple organ-specifi c 
and population-specifi c missions of the individual 
institutes and centers at the NIH. 22,23 Research funding 
streams were found to be inadequate and frequently 
aligned across disease-specifi c boundaries that were 
minimally relevant in the emergency care setting. 23 
The Institute of Medicine Report recommended an 
examination of the opportunities in emergency and 
trauma care research that in turn would motivate cre-
ation of a strategy to optimally organize and fund the 
research. 21 This in turn led to roundtables, requests 
for information, and conferences to address how 
the NIH and the extramural community might best 
advance research in the emergency setting. Implemen-
tation of the recommendations culminated recently in 
the creation of a new NIH Offi ce of Emergency Care 
Research (OECR). 24 The formation of the OECR 
is a groundbreaking advance not only for emergency 
care investigators and research but also for the new 
pathway it provides for expanded critical illness and 
injury research initiatives. The interdisciplinary, mul-
ticare setting and multiorgan system nature of critical 
illness and injury research can frequently run into 
the same type of funding stream hurdles that chal-
lenged emergency care research. We expect that the 
trans-NIH approach of OECR will provide a model 
to coordinate critical illness and injury research across 
the time and care setting continuum (prehospital to 
rehabilitation). 
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